Cambridge Investment Research Advisors’s COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH ABV Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ABV Stock Details ABV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-6,861	Closed	-$263K	–	1316
2013 Q3	$263K	Buy	6,861 +600	+10%	+$22K	0.01%	911
2013 Q2	$234K	Buy	+6,261	New	+$248K	0.01%	875

Other funds holding ABV

INCA Investments Miami, Florida $353M AUM 34.81% 1-Year Est. Return

HGI

Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return

Highmount Capital New York $391M AUM 2.65% 1-Year Est. Return

SIA

SeaBridge Investment Advisors Summit, New Jersey $692M AUM 52.26% 1-Year Est. Return

Cambridge Investment Research Advisors's ABV Position: Q4 2013 in Review

Cambridge Investment Research Advisors sold out of COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH (ABV) in Q4 2013, closing a stake of 6,861 shares — an estimated $263K sold.

Cambridge Investment Research Advisors first reported a position in ABV in Q2 2013 and held it in 2 quarters. The position peaked at $263K in Q3 2013. 4 funds tracked by Wall St. Rank hold ABV as of Q4 2013.

Cambridge Investment Research Advisors reported no remaining COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH position as of Q4 2013 after selling out during the quarter.
Cambridge Investment Research Advisors sold 6,861 COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH shares in Q4 2013, an estimated $263K.
Cambridge Investment Research Advisors first reported a position in COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH in Q2 2013 and held it in 2 quarters.
Cambridge Investment Research Advisors's COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH position peaked at $263K in Q3 2013.
4 funds tracked by Wall St. Rank held COMPANHIA BEBIDA ADS EACH REPSTG 1 PFD SH as of Q4 2013.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2013, filed 24 Jan 2014.